The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis
Expert Review of Clinical Pharmacology · 2024
DOI: 10.1080/17512433.2024.2313616 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Expert Review of Clinical Pharmacology, 2024. Verfasst von Bianca Vendruscolo Bianchini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Hypothyroidism, Thyrotropin, Thyroxine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: This systematic review aimed to compare the effect of alternative levothyroxine administration regimens on thyroid hormone levels and patient-reported outcomes (PROs) among adults with hypothyroidism. METHODS: We searched PubMed, Embase, CENTRAL, CINAHL, LILACS, SciELO, Scopus, Web of Science, OpenGrey, ProQuest, ClinicalTrials.gov, and ICTRP from inception to May/2023 for randomized controlled trials (RCTs). We assessed the risk of bias with Cochrane Risk of Bias 2.0 tool. We analyzed TSH levels by pairwise and network meta-analyses (NMA). The FT4 levels and PROs were qualitatively assessed. RESULTS: We included 14 RCTs (906 participants) comparing different regimens, as bedtime vs. before breakfast. A total of 12 RCTs were at high risk of bias. Seven RCTs were included in the TSH meta-analysis, where the mean difference (MD) and 95% confidence interval (CI) were as follows: bedtime vs before breakfast (4 RCTs) 0.69 (-1.67-3.04), I2 = 92%, very low certainty evidence; weekly dose vs before breakfast (2 RCTs) 1.68 (0.94-2.41), I2 = 0%, low certainty evidence; and at breakfast vs before breakfast (1 RCT) 0.65 (-1.11-2.41), very low certainty evidence. The NMA showed no evidence of differences in TSH level with different regimens. CONCLUSION: The evidence is insufficient to determine the most effective levothyroxine administration regimen for hypothyroidism. SYSTEMATIC REVIEW REGISTRATION: PROSPERO - CRD42021279375.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Postgraduate Program in Internal Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Postgraduate Program in Endocrinology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Postgraduate Program in Statistics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Postgraduate Program in Medicine, McGill University, Montreal, Quebec, Canada.
- Postgraduate Program in Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Bianca Vendruscolo Bianchini
Zitieren
APA
Bianchini, B. V., de Jesus, P. R., de Mello, R. G. B., Ziegelmann, P. K., Filion, K. B., & Dal Pizzol, T. D. S. (2024). The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2024.2313616
Vancouver
Bianchini BV, de Jesus PR, de Mello RGB, Ziegelmann PK, Filion KB, Dal Pizzol TDS. The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis. Expert Review of Clinical Pharmacology. 2024. doi:10.1080/17512433.2024.2313616
BibTeX
@article{Bianchini2024,
author = {Bianchini, Bianca Vendruscolo and de Jesus, Patricia Romualdo and de Mello, Renato Gorga Bandeira and Ziegelmann, Patricia Klarmann and Filion, Kristian Bellevue and Dal Pizzol, Tatiane da Silva},
title = {The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis},
journal = {Expert Review of Clinical Pharmacology},
year = {2024},
doi = {10.1080/17512433.2024.2313616}
}
EUVIMED